Original language | English |
---|---|
Pages (from-to) | 283-285 |
Number of pages | 3 |
Journal | Journal of Clinical Psychopharmacology |
Volume | 38 |
Issue number | 4 |
DOIs | |
State | Published - Aug 1 2018 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Clinical Psychopharmacology, Vol. 38, No. 4, 01.08.2018, p. 283-285.
Research output: Contribution to journal › Editorial
TY - JOUR
T1 - The Prescription of Benzodiazepines for Panic Disorder
T2 - Time for an Evidence-Based Educational Approach
AU - Nardi, Antonio E.
AU - Cosci, Fiammetta
AU - Balon, Richard
AU - Weintraub, Steven J.
AU - Freire, Rafael C.
AU - Krystal, John H.
AU - Roth, Thomas
AU - Silberman, Edward K.
AU - Sonino, Nicoletta
AU - Fava, Giovanni A.
AU - Starcevic, Vladan
AU - Dubovsky, Steven L.
AU - Salzman, Carl
AU - Rickels, Karl
AU - Greenblatt, David J.
AU - Shader, Richard I.
AU - Chouinard, Guy
N1 - Funding Information: From the *Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; †Department of Health Sciences, University of Florence, Florence, Italy; ‡Departments of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne State University School of Medicine, Detroit, MI; §Division of Hospital Medicine, Department of Medicine, Saint Louis Veterans Affairs Medical Center; and ||Department of Medicine, Washington University School of Medicine, St Louis, MO; ¶Departments of Psychiatry and #Neuroscience, Child Study Center, Yale University School of Medicine; **Psychiatry and Behavioral Health Services, Yale-New Haven Hospital, New Haven; and ††Clinical Neuroscience Division, National Center for Posttraumatic Stress Disorder, Veterans Affairs Connecticut Healthcare System, West Haven, CT; ‡‡Henry Ford Sleep Research Center, Henry Ford Hospital, Detroit, MI; §§Department of Psychiatry, Tufts Medical Center, Boston, MA; ||||University of Padova, Padova, Italy; Department of Psychiatry, University of Buffalo, Buffalo, NY; ¶¶Department of Psychology, University of Bologna, Italy; ##Department of Psychiatry, University of Buffalo, Buffalo, NY; ***Sydney Medical School–Nepean, University of Sydney, Sydney, Australia; †††Department of Psychiatry, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY; ‡‡‡Harvard Medical School, Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Boston, MA; §§§Department of Psychiatry, University of Pennsylvania, Philadelphia, PA; ||||||Program in Pharmacology and Experimental Therapeutics, Tufts University School of Medicine; and ¶¶¶Department of Immunology, Tufts University School of Medicine, Boston, MA; and ###Clinical Pharmacology and Toxicology Program, McGill University and Researcher Emeritus, Mental Health Institute of Montreal Fernand Seguin Research Centre, University of Montreal, Montreal, Quebec, Canada. Reprints: Antonio E. Nardi, MD, Institute of Psychiatry, Federal University of Rio de Janeiro, Rua Visconde de Piraja 407/702, Rio de Janeiro 22410-003 Brazil (e‐mail: [email protected]). Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved. ISSN: 0271-0749 DOI: 10.1097/JCP.0000000000000908
PY - 2018/8/1
Y1 - 2018/8/1
UR - http://www.scopus.com/inward/record.url?scp=85049795510&partnerID=8YFLogxK
U2 - 10.1097/JCP.0000000000000908
DO - 10.1097/JCP.0000000000000908
M3 - Editorial
C2 - 29912790
AN - SCOPUS:85049795510
SN - 0271-0749
VL - 38
SP - 283
EP - 285
JO - Journal of Clinical Psychopharmacology
JF - Journal of Clinical Psychopharmacology
IS - 4
ER -